AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28397981 — intervention group
Group type: EXPERIMENTAL
Intervention: Endometrial injury on cycle day 15-24
Number of subjects: 105
Study 28397981 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (control)
Number of subjects: 105
Study 26486868 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant tissue-type plasminogen activator 0.9 mg/kg
Number of subjects: 3035
Study 26486868 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure-lowering treatment during the first 24 hours
Number of subjects: 3035
Study 26486868 — intervention group
Group type: COMPARATOR
Intervention: High baseline blood pressure and high blood pressure variability
Number of subjects: 3035
Study 23964813 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization training
Number of subjects: 48
Study 23964813 — intervention group
Group type: COMPARATOR
Intervention: Didactic training
Number of subjects: 48
Study 21402563 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF therapy
Number of subjects: 635
Study 21402563 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional therapy
Number of subjects: 635
Study 19711188 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 61
Study 19711188 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 61
Study 19711188 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 61
Study 17341170 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-β1b
Number of subjects: 0
Study 15488777 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreous presentation (VP) with posterior chamber (PC) intraocular lens (IOL)
Number of subjects: 751
Study 15488777 — intervention group
Group type: COMPARATOR
Intervention: Nonvitreous presentation (NVP)
Number of subjects: 751
Study 15488777 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitreous presentation (VP)
Number of subjects: 751
Study 11450583 — intervention group
Group type: EXPERIMENTAL
Intervention: New paracentesis needle
Number of subjects: 45
Study 11450583 — intervention group
Group type: COMPARATOR
Intervention: Angiocath
Number of subjects: 45
Study 14518310 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial chemotherapy with 5-FU (1000 mg/m2 continuously over 5d/28d) and Folinic Acid (200 mg/m2 over 15 minutes 5d/28d)
Number of subjects: 226
Study 14518310 — intervention group
Group type: COMPARATOR
Intervention: Resection only (Control)
Number of subjects: 226
Study 7912249 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/day of ursodeoxycholic acid (Group A: 18 patients)
Number of subjects: 36
Study 7912249 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group B: 18 patients)
Number of subjects: 36
Study 7912249 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 2574656 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative management (surgery)
Number of subjects: 205
Study 2574656 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 205
Study 2574656 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative management (surgery) in Crohn's colitis
Number of subjects: 205
Study 2574656 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment in Crohn's colitis
Number of subjects: 205
Study 2574656 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative management (surgery) in ileocolitis
Number of subjects: 205
Study 2574656 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment in ileocolitis
Number of subjects: 205
Study 2574656 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative management (surgery) in ileitis
Number of subjects: 205
Study 2574656 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment in ileitis
Number of subjects: 205
Study 1092533 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine
Number of subjects: 8
Study 1092533 — intervention group
Group type: COMPARATOR
Intervention: Hydrophilic colloid
Number of subjects: 8
Study 30596892 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrogate intervention recovery of a DAG (sirDAG)
Number of subjects: 550
Study 28388220 — intervention group
Group type: EXPERIMENTAL
Intervention: One-day sleep workshop for insomnia
Number of subjects: 14
Study 28286287 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine-based treatment
Number of subjects: 1973
Study 28286287 — intervention group
Group type: EXPERIMENTAL
Intervention: Capecitabine in combination with oxaliplatin and bevacizumab
Number of subjects: 1973
Study 26251016 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim 2.5 µg/kg/day for 7 days
Number of subjects: 90
Study 26251016 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim 5 µg/kg/day for 7 days
Number of subjects: 90
Study 26251016 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim 10 µg/kg/day for 5 days
Number of subjects: 90
Study 26251016 — intervention group
Group type: COMPARATOR
Intervention: BK0023 (all doses)
Number of subjects: 90
Study 26251016 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 90
Study 23240876 — intervention group
Group type: EXPERIMENTAL
Intervention: GaAlAs laser light (830 nm, 100mW, 22 sec on vestibular and palatal surfaces)
Number of subjects: 60
Study 23240876 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (laser light off)
Number of subjects: 60
Study 21447912 — intervention group
Group type: EXPERIMENTAL
Intervention: Low frequency (1 Hz) rTMS applied to the anterior portion of a Broca's area homologue for 20 minutes per day for 10 days
Number of subjects: 12
Study 21447912 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 12
Study 19188371 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) intervention
Number of subjects: 189
Study 19188371 — intervention group
Group type: COMPARATOR
Intervention: Case management
Number of subjects: 189
Study 19188371 — intervention group
Group type: COMPARATOR
Intervention: Standard provider care
Number of subjects: 189
Study 14990833 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenal hematoma patients
Number of subjects: 51
Study 14990833 — intervention group
Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 51
Study 11555104 — intervention group
Group type: EXPERIMENTAL
Intervention: HBsAg stimulation of PBMC
Number of subjects: 4
Study 11555104 — intervention group
Group type: EXPERIMENTAL
Intervention: CD8+ T cell deletion
Number of subjects: 4
Study 9513097 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia EX adhesive
Number of subjects: 3
Study 9513097 — intervention group
Group type: COMPARATOR
Intervention: Copalite varnish
Number of subjects: 3
Study 9513097 — intervention group
Group type: EXPERIMENTAL
Intervention: High copper amalgam
Number of subjects: 3
Study 7740378 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteoporosis (OP) group
Number of subjects: 181
Study 7740378 — intervention group
Group type: COMPARATOR
Intervention: Non-OP control group
Number of subjects: 181
Study 3168567 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone 80 mg/24 h and aminophylline by continuous infusion (Group A)
Number of subjects: 0
Study 3168567 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release theophylline and methylprednisolone 80 mg in two equally divided doses by mouth (Group B)
Number of subjects: 0
Study 31515719 — intervention group
Group type: EXPERIMENTAL
Intervention: Inguinal lymphadenectomy
Number of subjects: 69
Study 31515719 — intervention group
Group type: EXPERIMENTAL
Intervention: Ilio-inguinal lymphadenectomy
Number of subjects: 69
Study 28592282 — intervention group
Group type: EXPERIMENTAL
Intervention: RAGT + VR (40 sessions of Lokomat with VR)
Number of subjects: 24
Study 28592282 — intervention group
Group type: COMPARATOR
Intervention: RAGT - VR (Lokomat without VR)
Number of subjects: 24
Study 25100217 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving with a cautious peer
Number of subjects: 0
Study 25100217 — intervention group
Group type: COMPARATOR
Intervention: Driving with a risky peer
Number of subjects: 0
Study 24332472 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic stimulus (touching a pad with index finger)
Number of subjects: 22
Study 24332472 — intervention group
Group type: EXPERIMENTAL
Intervention: Haptic stimulus (withdrawal of contact with pad)
Number of subjects: 22
Study 23306563 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial trigger point deactivation (10 sessions)
Number of subjects: 71
Study 23306563 — intervention group
Group type: COMPARATOR
Intervention: Sham deactivation (10 sessions)
Number of subjects: 71
Study 23306563 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofascial trigger point deactivation
Number of subjects: 71
Study 20560622 — intervention group
Group type: EXPERIMENTAL
Intervention: Brown diet (BD)
Number of subjects: 18
Study 20560622 — intervention group
Group type: COMPARATOR
Intervention: White diet (WD)
Number of subjects: 18
Study 17564002 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone, 4 mg i.v.
Number of subjects: 60
Study 17564002 — intervention group
Group type: COMPARATOR
Intervention: Ondansetron, 4 mg i.v.
Number of subjects: 60
Study 15606417 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization-based methods for times to repeated events
Number of subjects: 0
Study 15606417 — intervention group
Group type: EXPERIMENTAL
Intervention: Structural accelerated failure time models
Number of subjects: 0
Study 15606417 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial censoring techniques
Number of subjects: 0
Study 11522614 — intervention group
Group type: EXPERIMENTAL
Intervention: MEN 11420 (8 mg intravenously)
Number of subjects: 34
Study 11522614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 9632121 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum sex hormone-binding globulin (SHBG)
Number of subjects: 58
Study 7829401 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose metoclopramide plus dexamethasone (HDMP+Dx)
Number of subjects: 54
Study 7829401 — intervention group
Group type: COMPARATOR
Intervention: Granisetron plus dexamethasone (GRN+Dx)
Number of subjects: 54
Study 2826952 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms recombinant gamma‐interferon (rec‐gamma‐IFN)
Number of subjects: 10
Study 2826952 — intervention group
Group type: COMPARATOR
Intervention: 1.5 mg dexamethasone
Number of subjects: 10
Study 2826952 — intervention group
Group type: EXPERIMENTAL
Intervention: rec‐gamma‐IFN
Number of subjects: 10
Study 2826952 — intervention group
Group type: COMPARATOR
Intervention: pituitary cell culture
Number of subjects: 10
Study 30535174 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-implemented communication treatment
Number of subjects: 19
Study 30535174 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 19
Study 27501654 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide-timolol treatment
Number of subjects: 90
Study 27501654 — intervention group
Group type: COMPARATOR
Intervention: Balanced salt solution (Control)
Number of subjects: 90
Study 24712047 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mL liquid test meal consumed three times (breakfast, lunch, dinner)
Number of subjects: 15
Study 24712047 — intervention group
Group type: COMPARATOR
Intervention: 300 mL liquid test meal consumed six times (breakfast, snack, lunch, snack, dinner, snack)
Number of subjects: 15
Study 24712047 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mL regimen
Number of subjects: 15
Study 22159169 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azithromycin (1 g)
Number of subjects: 1452
Study 22159169 — intervention group
Group type: COMPARATOR
Intervention: Topical tetracycline (twice per day for 6 weeks)
Number of subjects: 1452
Study 20864405 — intervention group
Group type: EXPERIMENTAL
Intervention: Bortezomib
Number of subjects: 833
Study 20864405 — intervention group
Group type: COMPARATOR
Intervention: Vincristine
Number of subjects: 833
Study 19009864 — intervention group
Group type: EXPERIMENTAL
Intervention: Bladeless trocar (Optiview system)
Number of subjects: 60
Study 19009864 — intervention group
Group type: COMPARATOR
Intervention: Hasson open trocar
Number of subjects: 60
Study 15997934 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate
Number of subjects: 70
Study 15997934 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass ionomer
Number of subjects: 70
Study 15997934 — intervention group
Group type: COMPARATOR
Intervention: No barrier (positive control)
Number of subjects: 70
Study 15997934 — intervention group
Group type: COMPARATOR
Intervention: Sticky wax (negative control)
Number of subjects: 70
Study 12760313 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg/day
Number of subjects: 202
Study 12760313 — intervention group
Group type: COMPARATOR
Intervention: Naproxen 1 g/day
Number of subjects: 202
Study 10362745 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 12
Study 10362745 — intervention group
Group type: COMPARATOR
Intervention: L-NMMA
Number of subjects: 12
Study 10362745 — intervention group
Group type: COMPARATOR
Intervention: L-arginine
Number of subjects: 12
Study 8684755 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound and graded outpatient tocolysis
Number of subjects: 1765
Study 8684755 — intervention group
Group type: COMPARATOR
Intervention: Conventional methods without transvaginal ultrasound
Number of subjects: 1765
Study 8477316 — intervention group
Group type: EXPERIMENTAL
Intervention: Midnight removal of urinary catheters
Number of subjects: 0
Study 8477316 — intervention group
Group type: COMPARATOR
Intervention: 0600 removal of urinary catheters
Number of subjects: 0
Study 3698608 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefamandole nafate
Number of subjects: 80
Study 3698608 — intervention group
Group type: COMPARATOR
Intervention: Cephalothin sodium
Number of subjects: 80
Study 30187872 — intervention group
Group type: EXPERIMENTAL
Intervention: ethinyl oestradiol/cyproterone tablets (Group A)
Number of subjects: 712
Study 30187872 — intervention group
Group type: EXPERIMENTAL
Intervention: desogestrel/ethinyl oestradiol tablets (Group B)
Number of subjects: 712
Study 30187872 — intervention group
Group type: EXPERIMENTAL
Intervention: metformin (for women with insulin resistance)
Number of subjects: 712
Study 24567309 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily oral supplementation of multivitamins (B-complex, C and E)
Number of subjects: 2387
Study 24567309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2387
Study 22864036 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraocular irrigation fluid with epinephrine 1:1,000,000
Number of subjects: 88
Study 22864036 — intervention group
Group type: COMPARATOR
Intervention: Intraocular irrigation fluid without epinephrine (Control)
Number of subjects: 88
Study 20141304 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 0
Study 20141304 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 0
Study 17118949 — intervention group
Group type: EXPERIMENTAL
Intervention: Self management (n=73)
Number of subjects: 140
Study 17118949 — intervention group
Group type: COMPARATOR
Intervention: Standard care (n=67)
Number of subjects: 140
Study 15842871 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable appliance
Number of subjects: 30
Study 15842871 — intervention group
Group type: COMPARATOR
Intervention: Ordinary mandibular advancing appliance (Control)
Number of subjects: 30
Study 14606378 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural infusion of 400 micrograms/h of alfentanil with 50 mg/h of lidocaine (group T-AL)
Number of subjects: 45
Study 14606378 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural infusion of 400 micrograms/h of alfentanil (group T-A)
Number of subjects: 45
Study 14606378 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural infusion of 400 micrograms/h of alfentanil (group L-A)
Number of subjects: 45
Study 10065387 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 180
Study 10065387 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital care
Number of subjects: 180
Study 10065387 — intervention group
Group type: EXPERIMENTAL
Intervention: Job rehabilitation
Number of subjects: 180
Study 7711452 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol and midazolam
Number of subjects: 60
Study 7711452 — intervention group
Group type: COMPARATOR
Intervention: Propofol and fentanyl
Number of subjects: 60
Study 2675854 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained release oral salbutamol (8 mg)
Number of subjects: 15
Study 2675854 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol (8 mg)
Number of subjects: 15
Study 2675854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1171083 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 143
Study 1171083 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 143
Study 1171083 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 143
Study 1171083 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 143
Study 1171083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 31609772 — intervention group
Group type: EXPERIMENTAL
Intervention: Early triggered palliative care consultation
Number of subjects: 199
Study 31609772 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 199
Study 28017964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric balloon plus lifestyle intervention
Number of subjects: 255
Study 28017964 — intervention group
Group type: COMPARATOR
Intervention: Lifestyle intervention alone
Number of subjects: 255
Study 26253869 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐1 (40 mg/m² twice per day) for 2 consecutive weeks repeated every 3 weeks for 1 year
Number of subjects: 200
Study 26253869 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin (CDDP) (60 mg/m²) on day 1 plus oral S‐1 (40 mg/m² twice per day) for 2 consecutive weeks repeated every 3 weeks for four cycles
Number of subjects: 200
Study 22173149 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning administration (8:00 to 10:00 a.m.)
Number of subjects: 122
Study 22173149 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon administration (1:00 to 3:00 p.m.)
Number of subjects: 122
Study 22173149 — intervention group
Group type: EXPERIMENTAL
Intervention: ADHD classification using TOVA
Number of subjects: 122
Study 21381157 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care ERP (3 sessions over 6 weeks of low-intensity counseling with ERP bibliotherapy, followed by therapist-administered ERP if needed)
Number of subjects: 30
Study 21381157 — intervention group
Group type: COMPARATOR
Intervention: Standard ERP (therapist-administered ERP with no lower-intensity lead-in)
Number of subjects: 30
Study 21381157 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepped care ERP
Number of subjects: 30
Study 21381157 — intervention group
Group type: COMPARATOR
Intervention: Standard ERP
Number of subjects: 30
Study 21381157 — intervention group
Group type: COMPARATOR
Intervention: Stepped care ERP and Standard ERP
Number of subjects: 30
Study 18022318 — intervention group
Group type: EXPERIMENTAL
Intervention: Active laser treatment
Number of subjects: 43
Study 18022318 — intervention group
Group type: COMPARATOR
Intervention: Placebo laser treatment
Number of subjects: 43
Study 16546864 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (150 mg)
Number of subjects: 15
Study 12570118 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualised asthma programme directed at behavioural change
Number of subjects: 23
Study 12570118 — intervention group
Group type: COMPARATOR
Intervention: Waiting list condition
Number of subjects: 23
Study 10838018 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose intravenous administration of ivabradine
Number of subjects: 66
Study 10838018 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple dose oral administration of ivabradine every 12 hours
Number of subjects: 66
Study 9178278 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine-containing parenteral nutrition (PN)
Number of subjects: 84
Study 9178278 — intervention group
Group type: COMPARATOR
Intervention: Control parenteral nutrition (isonitrogenous, isoenergetic)
Number of subjects: 84
Study 8398222 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral risk factor surveys (BRFSs) for women binge drinkers
Number of subjects: 0
Study 8398222 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral risk factor surveys (BRFSs) for older drivers reporting drinking and driving or multiple drinking problems
Number of subjects: 0
Study 8398222 — intervention group
Group type: EXPERIMENTAL
Intervention: CAGE score of 2 or more for older drivers
Number of subjects: 0
Study 8398222 — intervention group
Group type: COMPARATOR
Intervention: Problem drinking behaviors in male drivers under 65 years of age
Number of subjects: 0
Study 3773498 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (caval atrial cannula)
Number of subjects: 20
Study 3773498 — intervention group
Group type: COMPARATOR
Intervention: Group 1 (single-port drainage cannulae)
Number of subjects: 20
Study 31567674 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Training Tool (CTT)
Number of subjects: 36
Study 31567674 — intervention group
Group type: COMPARATOR
Intervention: Standard operation manual with surgical videos
Number of subjects: 36
Study 29617350 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice Bran Soymilk (RBS)
Number of subjects: 17
Study 29617350 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-Free Soymilk (SFS)
Number of subjects: 17
Study 29617350 — intervention group
Group type: COMPARATOR
Intervention: White Bread (Control)
Number of subjects: 17
Study 27680405 — intervention group
Group type: EXPERIMENTAL
Intervention: New chimney-equipped stoves (n=155)
Number of subjects: 334
Study 27680405 — intervention group
Group type: COMPARATOR
Intervention: Open-fire stoves (n=179)
Number of subjects: 334
Study 22493975 — intervention group
Group type: EXPERIMENTAL
Intervention: BML training (30% of 1-RM load, 5-7 sets of 15 repetitions, 3 times per week for 8 weeks)
Number of subjects: 24
Study 22493975 — intervention group
Group type: EXPERIMENTAL
Intervention: BML training
Number of subjects: 24
Study 22493975 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=7)
Number of subjects: 24